Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A six-month interventional program to determine the biological and psychosocial effects of hula as a form of physical activity for female breast, cervical, endometrial or ovarian cancer survivors living on Oahu.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hula | Other | Hula is an ancient, Native Hawaiian dance form of cultural expression and physical activity. Participants will attend one-hour hula classes twice a week for six months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hula | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Hula Program Feasibility (Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention) | Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention | 6 months after the start of the intervention program |
| Measure | Description | Time Frame |
|---|---|---|
| Biomarkers - Sex Hormones (Circulating levels of sex hormones measured in serum samples) | Circulating levels of sex hormones measured in serum samples. | Baseline, 6 months and 12 months after the start of the intervention program |
| Biomarkers - Cytokines (Circulating levels of cytokines measured in serum samples.) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Erin Bantum, MA, PhD | University of Hawaii Cancer Research Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Hawaii Cancer Center | Honolulu | Hawaii | 96813 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 37941759 | Derived | Bantum EO, Yamada PM, Makolo T, Yu H, Pagano I, Subia N, Walsh C, Loo LWM. Hula as a physical activity and social support intervention for sustained activity in female breast and gynecologic cancer survivors. Front Psychol. 2023 Oct 24;14:1190532. doi: 10.3389/fpsyg.2023.1190532. eCollection 2023. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D001943 | Breast Neoplasms |
| D002583 | Uterine Cervical Neoplasms |
| D010051 | Ovarian Neoplasms |
| D016889 | Endometrial Neoplasms |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Circulating levels of cytokines measured in serum samples. |
| Baseline, 6 months and 12 months after the start of the intervention program |
| Biomarkers - Inflammatory Markers (Circulating levels of leptin, CRP, IGF-1, and IGFBP3 measured in serum samples collectively.) | Circulating levels of leptin, CRP, IGF-1, and IGFBP3 measured in serum samples collectively. | Baseline, 6 months and 12 months after the start of the intervention program |
| DNA Methylation Patterns (DNA methylation patterns as detected with the Illumina Assay containing methylation sites in RefSeq genes and CpG islands collectively.) | DNA methylation patterns as detected with the Illumina Assay containing methylation sites in RefSeq genes and CpG islands collectively. | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Demographics (Collectively looking at demographic items as measured on the baseline questionnaire, including ethnicity, education, family, history of cancer, stage of cancer, treatment type, and comorbidities.) | Collectively looking at demographic items as measured on the baseline questionnaire, including ethnicity, education, family, history of cancer, stage of cancer, treatment type, and comorbidities. | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Physical Activity (Minutes per week of exercise assessed using The Women's Health Initiative Physical Activity Questionnaire) | Minutes per week of exercise assessed using The Women's Health Initiative Physical Activity Questionnaire | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Health-Related Quality of Life (Quality of life of participants assessed using The European Organization for Research and Treatment of Cancer QLQ-C30.) | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Fatigue (assessed using The Brief Fatigue Inventory (BFI) | The severity and impact of fatigue on daily functioning assessed using The Brief Fatigue Inventory (BFI). | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Depression (indicated using The Centers for Epidemiological Studies Depression Scale (CES-ED) | The presence of depression as indicated using The Centers for Epidemiological Studies Depression Scale (CES-ED). | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Affective States (assessed using The Profile of Mood States short form (POMS-SF) questionnaire.) | Affect of participants assessed using The Profile of Mood States short form (POMS-SF) questionnaire. | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Social Constraints (assessed using The 10-item Social Constraints Scale.) | How people adjust and cope with a cancer diagnosis assessed using The 10-item Social Constraints Scale. | Baseline, 6 months and 12 months after the start of the intervention program |
| Self-Report Outcomes - Cognitive Functioning (assessed using the 42-item FACTcog | 2 subscales assess cognitive deficiency and cognitive capability | Baseline, 6 months and 12 months after the start of the intervention program |
| D012871 |
| Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D004701 | Endocrine Gland Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 | Adnexal Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |